Search by Drug Name or NDC

    NDC 00074-7034-02 Skyrizi Details

    Skyrizi

    Skyrizi is a KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AbbVie Inc.. The primary component is .

    Product Information

    NDC 00074-7034
    Product ID 0074-7034_7718dd85-622c-478e-ae9b-91e14a1373c6
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Skyrizi
    Proprietary Name Suffix n/a
    Non-Proprietary Name Risankizumab-rzaa
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form KIT
    Route n/a
    Active Ingredient Strength n/a
    Active Ingredient Units n/a
    Substance Name n/a
    Labeler Name AbbVie Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA761105
    Listing Certified Through 2025-12-31

    Package

    NDC 00074-7034-02 (00074703402)

    NDC Package Code 0074-7034-02
    Billing NDC 00074703402
    Package 2 CARTON in 1 CARTON (0074-7034-02) / 1 KIT in 1 CARTON * 2 SYRINGE, GLASS in 1 CARTON (0074-7032-90) / 1 mL in 1 SYRINGE, GLASS (0074-7032-01)
    Marketing Start Date 2023-03-22
    NDC Exclude Flag N
    Pricing Information N/A